California Public Employees Retirement System Trims Stock Holdings in Masimo Co. (NASDAQ:MASI)

California Public Employees Retirement System decreased its holdings in Masimo Co. (NASDAQ:MASIGet Rating) by 3.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 93,563 shares of the medical equipment provider’s stock after selling 3,310 shares during the period. California Public Employees Retirement System owned 0.17% of Masimo worth $12,226,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the business. Vanguard Group Inc. increased its stake in shares of Masimo by 1.5% in the first quarter. Vanguard Group Inc. now owns 4,775,660 shares of the medical equipment provider’s stock worth $695,050,000 after purchasing an additional 71,918 shares in the last quarter. State Street Corp boosted its position in shares of Masimo by 1.6% in the first quarter. State Street Corp now owns 1,730,991 shares of the medical equipment provider’s stock valued at $251,928,000 after acquiring an additional 27,261 shares during the period. Liontrust Investment Partners LLP boosted its position in shares of Masimo by 19.0% in the second quarter. Liontrust Investment Partners LLP now owns 1,199,300 shares of the medical equipment provider’s stock valued at $156,713,000 after acquiring an additional 191,700 shares during the period. RTW Investments LP boosted its position in shares of Masimo by 32.7% in the first quarter. RTW Investments LP now owns 1,127,593 shares of the medical equipment provider’s stock valued at $164,110,000 after acquiring an additional 277,622 shares during the period. Finally, Champlain Investment Partners LLC boosted its position in shares of Masimo by 0.6% in the first quarter. Champlain Investment Partners LLC now owns 975,547 shares of the medical equipment provider’s stock valued at $141,981,000 after acquiring an additional 5,860 shares during the period. Hedge funds and other institutional investors own 93.31% of the company’s stock.

Masimo Trading Up 3.2 %

Shares of Masimo stock opened at $141.46 on Monday. The firm has a market cap of $7.44 billion, a PE ratio of 46.84 and a beta of 0.87. The company has a debt-to-equity ratio of 0.76, a current ratio of 2.12 and a quick ratio of 1.28. Masimo Co. has a 1 year low of $108.89 and a 1 year high of $305.21. The company has a 50 day simple moving average of $137.02 and a two-hundred day simple moving average of $139.35.

Insider Transactions at Masimo

In other Masimo news, CEO Joe E. Kiani acquired 7,784 shares of the stock in a transaction dated Friday, November 11th. The stock was purchased at an average cost of $129.27 per share, for a total transaction of $1,006,237.68. Following the acquisition, the chief executive officer now owns 7,784 shares in the company, valued at approximately $1,006,237.68. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other Masimo news, CEO Joe E. Kiani acquired 7,784 shares of the stock in a transaction dated Friday, November 11th. The stock was purchased at an average cost of $129.27 per share, for a total transaction of $1,006,237.68. Following the acquisition, the chief executive officer now owns 7,784 shares in the company, valued at approximately $1,006,237.68. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Joe E. Kiani acquired 31,994 shares of the stock in a transaction dated Monday, November 14th. The stock was acquired at an average price of $123.99 per share, with a total value of $3,966,936.06. Following the completion of the acquisition, the chief executive officer now owns 39,778 shares in the company, valued at approximately $4,932,074.22. The disclosure for this purchase can be found here. Company insiders own 9.70% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have recently commented on MASI shares. Needham & Company LLC raised their price objective on shares of Masimo from $163.00 to $179.00 and gave the company a “buy” rating in a research report on Wednesday, August 10th. Piper Sandler cut their price objective on shares of Masimo from $150.00 to $135.00 and set a “neutral” rating for the company in a research report on Wednesday, November 9th. Stifel Nicolaus lifted their target price on shares of Masimo from $162.00 to $172.00 and gave the company a “buy” rating in a research report on Monday, September 12th. Wolfe Research upgraded shares of Masimo from a “peer perform” rating to an “outperform” rating and set a $165.00 target price for the company in a research report on Thursday, September 15th. Finally, Jefferies Financial Group assumed coverage on shares of Masimo in a research report on Wednesday, October 12th. They set a “buy” rating and a $180.00 target price for the company. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat.com, Masimo currently has an average rating of “Moderate Buy” and an average price target of $190.29.

Masimo Profile

(Get Rating)

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

See Also

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.